Oorsprong van het eerstegraads netwerk van Hugo Katus
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
AaviGen GmbH
 AaviGen GmbH BiotechnologyHealth Technology AaviGen GmbH is a German pre-clinical biotechnology company that focuses on developing curative gene therapies. The company is based in Heidelberg, Germany. AaviGen was founded by Martin Busch, Marc Lerchenmueller, Hugo Katus, and Patrick Most. Patrick Most has been the CEO since incorporation.
3
| Holding Company | Biotechnology | 3 |
uniQure GmbH
 uniQure GmbH BiotechnologyHealth Technology Part of uniQure NV, uniQure GmbH is a German company that provides research and development services of human gene-based therapies. The company is based in Heidelberg, Germany. The company was founded by Hugo Katus, Patrick Most. uniQure was acquired by uniQure NV on August 11, 2014 for $4.02 million.
1
| Subsidiary | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hugo Katus via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|
Statistieken
Internationaal
Sectoraal
Operationeel
| Founder | 4 |
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
| Chief Operating Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Patrick Most | 2 |
| Marc Lerchenmueller | 1 |
| Martin Busch | 1 |
- Beurs
- Insiders
- Hugo Katus
- Bedrijfsconnecties
